EP2024512A4 - Méthodes pour le diagnostic de caractères anormaux f taux - Google Patents

Méthodes pour le diagnostic de caractères anormaux f taux

Info

Publication number
EP2024512A4
EP2024512A4 EP07784442A EP07784442A EP2024512A4 EP 2024512 A4 EP2024512 A4 EP 2024512A4 EP 07784442 A EP07784442 A EP 07784442A EP 07784442 A EP07784442 A EP 07784442A EP 2024512 A4 EP2024512 A4 EP 2024512A4
Authority
EP
European Patent Office
Prior art keywords
diagnosis
methods
fetal abnormalities
abnormalities
fetal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07784442A
Other languages
German (de)
English (en)
Other versions
EP2024512A2 (fr
Inventor
Ravi Kapur
Mehmet Toner
Zihua Wang
Martin Fuchs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Cellective DX Corp
Verinata Health Inc
Original Assignee
General Hospital Corp
Cellective DX Corp
Artemis Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp, Cellective DX Corp, Artemis Health Inc filed Critical General Hospital Corp
Priority to EP12175907A priority Critical patent/EP2548972A1/fr
Priority to EP22194250.1A priority patent/EP4170042A1/fr
Priority to EP11159371.1A priority patent/EP2366801B1/fr
Priority to EP18167847.5A priority patent/EP3406736B1/fr
Publication of EP2024512A2 publication Critical patent/EP2024512A2/fr
Publication of EP2024512A4 publication Critical patent/EP2024512A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N2015/1006—Investigating individual particles for cytology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N2015/1029—Particle size

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP07784442A 2006-06-14 2007-06-14 Méthodes pour le diagnostic de caractères anormaux f taux Withdrawn EP2024512A4 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP12175907A EP2548972A1 (fr) 2006-06-14 2007-06-14 Procédés pour le diagnostic dýanomalies fýtales
EP22194250.1A EP4170042A1 (fr) 2006-06-14 2007-06-14 Procédés pour le diagnostic d'anomalies f tales
EP11159371.1A EP2366801B1 (fr) 2006-06-14 2007-06-14 Procédés pour le diagnostic d'anomalies foetales
EP18167847.5A EP3406736B1 (fr) 2006-06-14 2007-06-14 Procédés pour le diagnostic d'anomalies fétales

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80481706P 2006-06-14 2006-06-14
US82077806P 2006-07-28 2006-07-28
PCT/US2007/071250 WO2007147076A2 (fr) 2006-06-14 2007-06-14 Méthodes pour le diagnostic de caractères anormaux fœtaux

Related Child Applications (3)

Application Number Title Priority Date Filing Date
EP11159371.1A Division EP2366801B1 (fr) 2006-06-14 2007-06-14 Procédés pour le diagnostic d'anomalies foetales
EP18167847.5A Division EP3406736B1 (fr) 2006-06-14 2007-06-14 Procédés pour le diagnostic d'anomalies fétales
EP22194250.1A Division EP4170042A1 (fr) 2006-06-14 2007-06-14 Procédés pour le diagnostic d'anomalies f tales

Publications (2)

Publication Number Publication Date
EP2024512A2 EP2024512A2 (fr) 2009-02-18
EP2024512A4 true EP2024512A4 (fr) 2009-12-09

Family

ID=38832875

Family Applications (5)

Application Number Title Priority Date Filing Date
EP18167847.5A Active EP3406736B1 (fr) 2006-06-14 2007-06-14 Procédés pour le diagnostic d'anomalies fétales
EP12175907A Withdrawn EP2548972A1 (fr) 2006-06-14 2007-06-14 Procédés pour le diagnostic dýanomalies fýtales
EP11159371.1A Active EP2366801B1 (fr) 2006-06-14 2007-06-14 Procédés pour le diagnostic d'anomalies foetales
EP22194250.1A Pending EP4170042A1 (fr) 2006-06-14 2007-06-14 Procédés pour le diagnostic d'anomalies f tales
EP07784442A Withdrawn EP2024512A4 (fr) 2006-06-14 2007-06-14 Méthodes pour le diagnostic de caractères anormaux f taux

Family Applications Before (4)

Application Number Title Priority Date Filing Date
EP18167847.5A Active EP3406736B1 (fr) 2006-06-14 2007-06-14 Procédés pour le diagnostic d'anomalies fétales
EP12175907A Withdrawn EP2548972A1 (fr) 2006-06-14 2007-06-14 Procédés pour le diagnostic dýanomalies fýtales
EP11159371.1A Active EP2366801B1 (fr) 2006-06-14 2007-06-14 Procédés pour le diagnostic d'anomalies foetales
EP22194250.1A Pending EP4170042A1 (fr) 2006-06-14 2007-06-14 Procédés pour le diagnostic d'anomalies f tales

Country Status (3)

Country Link
EP (5) EP3406736B1 (fr)
HK (1) HK1162610A1 (fr)
WO (1) WO2007147076A2 (fr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITBO20050481A1 (it) 2005-07-19 2007-01-20 Silicon Biosystems S R L Metodo ed apparato per la manipolazione e/o l'individuazione di particelle
US10081839B2 (en) * 2005-07-29 2018-09-25 Natera, Inc System and method for cleaning noisy genetic data and determining chromosome copy number
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
ITBO20050646A1 (it) 2005-10-26 2007-04-27 Silicon Biosystem S R L Metodo ed apparato per la caratterizzazione ed il conteggio di particelle
ITTO20060226A1 (it) 2006-03-27 2007-09-28 Silicon Biosystem S P A Metodo ed apparato per il processamento e o l'analisi e o la selezione di particelle, in particolare particelle biologiche
EP2029779A4 (fr) 2006-06-14 2010-01-20 Living Microsystems Inc Utilisation de génotypage snp fortement parallèle pour diagnostic fétal
US20080026390A1 (en) * 2006-06-14 2008-01-31 Roland Stoughton Diagnosis of Fetal Abnormalities by Comparative Genomic Hybridization Analysis
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US20100112590A1 (en) 2007-07-23 2010-05-06 The Chinese University Of Hong Kong Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing With Enrichment
PT2183693E (pt) 2007-07-23 2014-01-14 Univ Hong Kong Chinese Diagnóstico de aneuploidia cromossómica fetal utilizando sequenciação genómica
ITTO20070771A1 (it) 2007-10-29 2009-04-30 Silicon Biosystems Spa Metodo e apparato per la identificazione e manipolazione di particelle
US10895575B2 (en) 2008-11-04 2021-01-19 Menarini Silicon Biosystems S.P.A. Method for identification, selection and analysis of tumour cells
IT1391619B1 (it) * 2008-11-04 2012-01-11 Silicon Biosystems Spa Metodo per l'individuazione, selezione e analisi di cellule tumorali
CN102427883B (zh) 2009-03-17 2014-08-20 硅生物系统股份公司 用于细胞隔离的微流体装置
SG175282A1 (en) 2009-04-21 2011-11-28 Genetic Technologies Ltd Methods for obtaining fetal genetic material
CN102597266A (zh) 2009-09-30 2012-07-18 纳特拉公司 无创性产前倍性调用的方法
US20120315633A1 (en) 2009-12-23 2012-12-13 Genetic Technologies Limited Methods of enriching and detecting fetal nucleic acids
US20110312503A1 (en) 2010-01-23 2011-12-22 Artemis Health, Inc. Methods of fetal abnormality detection
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
CA3037126C (fr) 2010-05-18 2023-09-12 Natera, Inc. Procedes de classification de ploidie prenatale non invasive
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
RU2620959C2 (ru) 2010-12-22 2017-05-30 Натера, Инк. Способы неинвазивного пренатального установления отцовства
IT1403518B1 (it) 2010-12-22 2013-10-31 Silicon Biosystems Spa Dispositivo microfluidico per la manipolazione di particelle
EP3940084A1 (fr) 2011-02-09 2022-01-19 Bio-Rad Laboratories, Inc. Analyse d'acides nucléiques
ITTO20110990A1 (it) 2011-10-28 2013-04-29 Silicon Biosystems Spa Metodo ed apparato per l'analisi ottica di particelle a basse temperature
ITBO20110766A1 (it) 2011-12-28 2013-06-29 Silicon Biosystems Spa Dispositivi, apparato, kit e metodo per il trattamento di un campione biologico
WO2014078739A1 (fr) * 2012-11-15 2014-05-22 The General Hospital Corporation Procédés et systèmes permettant de diagnostiquer des anomalies prénatales
CN113512522A (zh) 2013-03-15 2021-10-19 普林斯顿大学理事会 用于高通量纯化的方法和设备
US20150064153A1 (en) 2013-03-15 2015-03-05 The Trustees Of Princeton University High efficiency microfluidic purification of stem cells to improve transplants
CN105264127B (zh) 2013-03-15 2019-04-09 Gpb科学有限责任公司 颗粒的片上微流体处理
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
CN106460070B (zh) 2014-04-21 2021-10-08 纳特拉公司 检测染色体片段中的突变和倍性
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
EP3294906A1 (fr) 2015-05-11 2018-03-21 Natera, Inc. Procédés et compositions pour la détermination de la ploïdie
ES2745556T3 (es) 2015-07-29 2020-03-02 Progenity Inc Acidos nucleicos y métodos para detectar anomalías cromosómicas
CN108473955B (zh) * 2016-02-03 2022-02-01 深圳华大生命科学研究院 从血液样本中分离靶细胞的方法及其用途
WO2018067517A1 (fr) 2016-10-04 2018-04-12 Natera, Inc. Procédés pour caractériser une variation de nombre de copies à l'aide d'un séquençage de ligature de proximité
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
EP3585889A1 (fr) 2017-02-21 2020-01-01 Natera, Inc. Compositions, procédés, et kits d'isolement d'acides nucléiques
CN108118094A (zh) * 2018-03-06 2018-06-05 杨祚璋 骨肉瘤转移相关标志物ensg00000267886及其应用
US11525159B2 (en) 2018-07-03 2022-12-13 Natera, Inc. Methods for detection of donor-derived cell-free DNA
EP3947718A4 (fr) 2019-04-02 2022-12-21 Enumera Molecular, Inc. Procédés, systèmes et compositions de comptage de molécules d'acide nucléique
EP4058185A4 (fr) * 2019-11-14 2023-11-29 Bio-Rad Laboratories, Inc. Détermination basée sur une partition d'un nombre de copies cible pour des cellules individuelles par amplification sans point d'extrémité

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999022868A1 (fr) * 1997-10-31 1999-05-14 Bbi Bioseq, Inc. Purification et extraction ameliorees sous haute pression
WO2000040750A1 (fr) * 1998-12-30 2000-07-13 Gyros Ab Procede de sequençage d'adn a l'aide d'un dispositif microfluidique
US20030165852A1 (en) * 2000-11-15 2003-09-04 Schueler Paula A. Methods and reagents for identifying rare fetal cells in the maternal circulation
WO2004029221A2 (fr) * 2002-09-27 2004-04-08 The General Hospital Corporation Dispositif microfluidique pour la separation de cellules et utilisations de ce dispositif

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242794A (en) 1984-12-13 1993-09-07 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
JPH0610416B2 (ja) 1987-12-28 1994-02-09 いすゞ自動車株式会社 回転電機付ターボチャージャの制御装置
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US4988617A (en) 1988-03-25 1991-01-29 California Institute Of Technology Method of detecting a nucleotide change in nucleic acids
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US6054270A (en) 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US6346413B1 (en) 1989-06-07 2002-02-12 Affymetrix, Inc. Polymer arrays
US5302509A (en) * 1989-08-14 1994-04-12 Beckman Instruments, Inc. Method for sequencing polynucleotides
US5641628A (en) * 1989-11-13 1997-06-24 Children's Medical Center Corporation Non-invasive method for isolation and detection of fetal DNA
US5494810A (en) 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
US5427663A (en) 1993-06-08 1995-06-27 British Technology Group Usa Inc. Microlithographic array for macromolecule and cell fractionation
DE69527585T2 (de) 1994-06-08 2003-04-03 Affymetrix Inc Verfahren und Vorrichtung zum Verpacken von Chips
US6287850B1 (en) 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture
US5733729A (en) 1995-09-14 1998-03-31 Affymetrix, Inc. Computer-aided probability base calling for arrays of nucleic acid probes on chips
US5799637A (en) 1996-05-01 1998-09-01 Cifuni; Charles G. Rocket effect sparking plug
US6969488B2 (en) 1998-05-22 2005-11-29 Solexa, Inc. System and apparatus for sequential processing of analytes
CA2335951C (fr) 1998-06-24 2013-07-30 Mark S. Chee Decodage de detecteurs matriciels a microspheres
US20040106110A1 (en) 1998-07-30 2004-06-03 Solexa, Ltd. Preparation of polynucleotide arrays
US20030022207A1 (en) 1998-10-16 2003-01-30 Solexa, Ltd. Arrayed polynucleotides and their use in genome analysis
US6787308B2 (en) 1998-07-30 2004-09-07 Solexa Ltd. Arrayed biomolecules and their use in sequencing
US7510841B2 (en) 1998-12-28 2009-03-31 Illumina, Inc. Methods of making and using composite arrays for the detection of a plurality of target analytes
US6429027B1 (en) 1998-12-28 2002-08-06 Illumina, Inc. Composite arrays utilizing microspheres
US6846460B1 (en) 1999-01-29 2005-01-25 Illumina, Inc. Apparatus and method for separation of liquid phases of different density and for fluorous phase organic syntheses
ATE469699T1 (de) * 1999-02-23 2010-06-15 Caliper Life Sciences Inc Manipulation von mikroteilchen in mikrofluiden systemen
US6355431B1 (en) 1999-04-20 2002-03-12 Illumina, Inc. Detection of nucleic acid amplification reactions using bead arrays
US20050191698A1 (en) 1999-04-20 2005-09-01 Illumina, Inc. Nucleic acid sequencing using microsphere arrays
US7056661B2 (en) 1999-05-19 2006-06-06 Cornell Research Foundation, Inc. Method for sequencing nucleic acid molecules
US6544732B1 (en) 1999-05-20 2003-04-08 Illumina, Inc. Encoding and decoding of array sensors utilizing nanocrystals
EP1190100B1 (fr) 1999-05-20 2012-07-25 Illumina, Inc. Decodage combinatoire de jeux d'acides nucleiques aleatoires
DE60030436T2 (de) 1999-05-20 2007-03-29 Illumina, Inc., San Diego Vorrichtung zur halterung und präsentation von mindestens einer mikrokugelmatrix zu lösungen und/oder zu optischen abbildungssystemen
EP1212599A2 (fr) 1999-08-30 2002-06-12 Illumina, Inc. Procedes permettant d'ameliorer la detection de signaux dans un jeu d'echantillons
US7211390B2 (en) 1999-09-16 2007-05-01 454 Life Sciences Corporation Method of sequencing a nucleic acid
US7244559B2 (en) 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
US6505125B1 (en) 1999-09-28 2003-01-07 Affymetrix, Inc. Methods and computer software products for multiple probe gene expression analysis
WO2001023610A2 (fr) 1999-09-29 2001-04-05 Solexa Ltd. Sequençage de polynucleotides
US6692952B1 (en) 1999-11-10 2004-02-17 Massachusetts Institute Of Technology Cell analysis and sorting apparatus for manipulation of cells
EP1239952B1 (fr) 1999-12-13 2011-10-05 Illumina, Inc. Dispositif de synthese d'oligonucleotides
US6582938B1 (en) 2001-05-11 2003-06-24 Affymetrix, Inc. Amplification of nucleic acids
GB0002389D0 (en) 2000-02-02 2000-03-22 Solexa Ltd Molecular arrays
US6913884B2 (en) 2001-08-16 2005-07-05 Illumina, Inc. Compositions and methods for repetitive use of genomic DNA
ATE360095T1 (de) 2000-02-07 2007-05-15 Illumina Inc Nukleinsäure nachweisverfahren mit universellem priming
WO2001057269A2 (fr) 2000-02-07 2001-08-09 Illumina, Inc. Procedes de detection d'acide nucleique par amorçage universel
US6770441B2 (en) 2000-02-10 2004-08-03 Illumina, Inc. Array compositions and methods of making same
GB0016742D0 (en) * 2000-07-10 2000-08-30 Simeg Limited Diagnostic method
AU2001293163A1 (en) 2000-09-27 2002-04-08 Lynx Therapeutics, Inc. Method for determining relative abundance of nucleic acid sequences
AU2002246612B2 (en) 2000-10-24 2007-11-01 The Board Of Trustees Of The Leland Stanford Junior University Direct multiplex characterization of genomic DNA
US7078168B2 (en) * 2001-02-27 2006-07-18 Biotage Ab Method for determining allele frequencies
DE10120797B4 (de) 2001-04-27 2005-12-22 Genovoxx Gmbh Verfahren zur Analyse von Nukleinsäureketten
FR2824144B1 (fr) * 2001-04-30 2004-09-17 Metagenex S A R L Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel
AU2002337030A1 (en) 2001-08-29 2003-03-18 Genovoxx Gmbh Method for analyzing nucleic acid sequences and gene expression
DE10246005A1 (de) 2001-10-04 2003-04-30 Genovoxx Gmbh Gerät zur Sequenzierung von Nukleinsäuremolekülen
DE10149786B4 (de) 2001-10-09 2013-04-25 Dmitry Cherkasov Oberfläche für Untersuchungen aus Populationen von Einzelmolekülen
US6956114B2 (en) 2001-10-30 2005-10-18 '454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US6902921B2 (en) 2001-10-30 2005-06-07 454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US20050124022A1 (en) 2001-10-30 2005-06-09 Maithreyan Srinivasan Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US20050244843A1 (en) * 2001-11-16 2005-11-03 Wen-Tien Chen Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
WO2003065019A1 (fr) 2002-01-25 2003-08-07 Illumina, Inc. Reseaux de capteurs servant a detecter des analytes dans des fluides
DE10214395A1 (de) 2002-03-30 2003-10-23 Dmitri Tcherkassov Verfahren zur Analyse von Einzelnukleotidpolymorphismen
US7727720B2 (en) * 2002-05-08 2010-06-01 Ravgen, Inc. Methods for detection of genetic disorders
JP2004065736A (ja) 2002-08-08 2004-03-04 Nemoto Kyorindo:Kk 薬液注入装置
WO2004037374A2 (fr) * 2002-10-23 2004-05-06 The Trustees Of Princeton University Procede de separation continue de particules faisant appel a des reseaux d'obstacles alignes de maniere asymetrique par rapport a des champs
EP1578994A2 (fr) 2002-11-11 2005-09-28 Affymetrix, Inc. Procedes pour identifier des changements du nombre de copies adn
WO2004044651A1 (fr) 2002-11-13 2004-05-27 Molecular Imprints, Inc. Systeme de mandrin et procede de modulation des formes de substrats
EP2159285B1 (fr) 2003-01-29 2012-09-26 454 Life Sciences Corporation Procédés d'amplification et de séquençage d'acides nucléiques
US7025935B2 (en) 2003-04-11 2006-04-11 Illumina, Inc. Apparatus and methods for reformatting liquid samples
US8150626B2 (en) 2003-05-15 2012-04-03 Illumina, Inc. Methods and compositions for diagnosing lung cancer with specific DNA methylation patterns
WO2004113877A1 (fr) 2003-06-13 2004-12-29 The General Hospital Corporation Systemes microfluidiques d'elimination basee sur la taille de globules rouges et de plaquettes du sang
US20050181394A1 (en) 2003-06-20 2005-08-18 Illumina, Inc. Methods and compositions for whole genome amplification and genotyping
JP2007508017A (ja) * 2003-10-08 2007-04-05 ザ トラスティーズ オブ ボストン ユニバーシティ 染色体異常の出生前診断のための方法
EP1725572B1 (fr) 2003-11-05 2017-05-31 AGCT GmbH Composes nucleotidiques macromoleculaires et leurs procedes d'utilisation
DE10356837A1 (de) 2003-12-05 2005-06-30 Dmitry Cherkasov Modifizierte Nukleotide und Nukleoside
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
US7040959B1 (en) 2004-01-20 2006-05-09 Illumina, Inc. Variable rate dispensing system for abrasive material and method thereof
US20050266432A1 (en) 2004-02-26 2005-12-01 Illumina, Inc. Haplotype markers for diagnosing susceptibility to immunological conditions
DE102004009704A1 (de) 2004-02-27 2005-09-15 Dmitry Cherkasov Makromolekulare Nukleotidverbindungen und Methoden zu deren Anwendung
CA2557819A1 (fr) * 2004-03-03 2005-09-15 The General Hospital Corporation Dispositif magnetique destine a l'isolation de cellules et de biomolecules dans un environnement microfluidique
US7035740B2 (en) 2004-03-24 2006-04-25 Illumina, Inc. Artificial intelligence and global normalization methods for genotyping
DE102004025744A1 (de) 2004-05-26 2005-12-29 Dmitry Cherkasov Oberfläche für die Analysen an einzelnen Nukleinsäuremolekülen
DE102004025694A1 (de) 2004-05-26 2006-02-23 Dmitry Cherkasov Verfahren und Oberfläche zu hochparallelen Analysen von Nukleinsäureketten
DE102004025745A1 (de) 2004-05-26 2005-12-15 Cherkasov, Dmitry Oberfläche für die Analysen an einzelnen Molekülen
DE102004025696A1 (de) 2004-05-26 2006-02-23 Dmitry Cherkasov Verfahren, Oberfläche und Substrate zu hochparallelen Analysen von Nukleinsäureketten
DE102004025746A1 (de) 2004-05-26 2005-12-15 Dmitry Cherkasov Verfahren, Oberfläche und Substrate zur hochparallelen Sequenzierung von Nukleinsäureketten
DE102004025695A1 (de) 2004-05-26 2006-02-23 Dmitry Cherkasov Verfahren und Oberfläche zur parallelen Sequenzierung von Nukleinsäureketten
US20060024711A1 (en) 2004-07-02 2006-02-02 Helicos Biosciences Corporation Methods for nucleic acid amplification and sequence determination
US7276720B2 (en) 2004-07-19 2007-10-02 Helicos Biosciences Corporation Apparatus and methods for analyzing samples
US20060012793A1 (en) 2004-07-19 2006-01-19 Helicos Biosciences Corporation Apparatus and methods for analyzing samples
US20060019258A1 (en) 2004-07-20 2006-01-26 Illumina, Inc. Methods and compositions for detection of small interfering RNA and micro-RNA
US20060024678A1 (en) 2004-07-28 2006-02-02 Helicos Biosciences Corporation Use of single-stranded nucleic acid binding proteins in sequencing

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999022868A1 (fr) * 1997-10-31 1999-05-14 Bbi Bioseq, Inc. Purification et extraction ameliorees sous haute pression
WO2000040750A1 (fr) * 1998-12-30 2000-07-13 Gyros Ab Procede de sequençage d'adn a l'aide d'un dispositif microfluidique
US20030165852A1 (en) * 2000-11-15 2003-09-04 Schueler Paula A. Methods and reagents for identifying rare fetal cells in the maternal circulation
WO2004029221A2 (fr) * 2002-09-27 2004-04-08 The General Hospital Corporation Dispositif microfluidique pour la separation de cellules et utilisations de ce dispositif

Also Published As

Publication number Publication date
EP2366801A1 (fr) 2011-09-21
EP3406736A1 (fr) 2018-11-28
EP2548972A1 (fr) 2013-01-23
WO2007147076A3 (fr) 2008-04-03
WO2007147076A2 (fr) 2007-12-21
EP2366801B1 (fr) 2016-10-19
HK1162610A1 (zh) 2012-08-31
EP4170042A1 (fr) 2023-04-26
EP3406736B1 (fr) 2022-09-07
EP2024512A2 (fr) 2009-02-18

Similar Documents

Publication Publication Date Title
HK1162610A1 (zh) 診斷胎兒畸形的方法
EP2029779A4 (fr) Utilisation de génotypage snp fortement parallèle pour diagnostic fétal
EP2029778A4 (fr) Diagnostic d'anomalies foetales à l'aide de polymorphismes, notamment de séquences courtes répétées en tandem
GB0610292D0 (en) Heart monitor
PL2185068T3 (pl) Monitorowanie płodu
EP2151194A4 (fr) Appareil de diagnostic à ultrasons
PT2029220E (pt) Sonda médica
EP2158326A4 (fr) Marqueurs biologiques pour le diagnostic d'une maladie auto-immune
EP2064996A4 (fr) Système de diagnostic de sein à ultrasons
IL194984A0 (en) Novel fetal markers for prenatal diagnosis and monitoring
EP2064995A4 (fr) Système de diagnostic de sein à ultrasons
EP1990009A4 (fr) Equipement de diagnostic ultrasonore
EP2144166A4 (fr) Système de diagnostic
GB0716885D0 (en) Diagnostic agent
AU310642S (en) Diagnostic meter
AU312219S (en) Diagnostic meter
EP1927317A4 (fr) Equipement diagnostique ultrasonore
EP2016172A4 (fr) Procedes de diagnostic destines a determiner un traitement
EP1980209A4 (fr) Sonde a ultrasons
EP2304437A4 (fr) Aide au diagnostic spécifique à une maladie
EP2324063A4 (fr) Génotypage rhd foetal non invasif à partir de sang maternel entier
IL210424A0 (en) Diagnostic snps for cardiac diseases
ZA200900638B (en) Method of diagnosis
HK1110655A1 (en) Diagnostic signal processor
HK1138376A1 (en) Clinical intervention directed diagnostic methods

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081212

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIC1 Information provided on ipc code assigned before grant

Ipc: C12P 19/34 20060101ALI20090128BHEP

Ipc: G01N 33/48 20060101ALI20090128BHEP

Ipc: C12Q 1/68 20060101AFI20090128BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE GENERAL HOSPITAL CORPORATION

Owner name: CELLECTIVE DX CORPORATION

Owner name: ARTEMIS HEALTH, INC.

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1127892

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20091109

17Q First examination report despatched

Effective date: 20100702

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE GENERAL HOSPITAL CORPORATION

Owner name: CELLECTIVE DX CORPORATION

Owner name: VERINATA HEALTH, INC

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE GENERAL HOSPITAL CORPORATION

Owner name: CELLECTIVE DX CORPORATION

Owner name: VERINATA HEALTH, INC

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120905

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1127892

Country of ref document: HK